J&J, Imerys unit must pay $117 million in N.J. asbestos cancer case

Share this post

NEW YORK (Reuters) – Johnson & Johnson and Imerys Talc America, a unit of Imerys SA, must pay $117 million in damages in a case involving a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply